Dr. Arusell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 4th Ave N #4040
Fargo, ND 58102Phone+1 701-234-6161
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 1981 - 1984
- University of North DakotaResidency, Internal Medicine, 1977 - 1979
- University of North Dakota School of Medicine and Health SciencesClass of 1976
Certifications & Licensure
- ND State Medical License 1977 - 2018
- MN State Medical License 1981 - 2017
- American Board of Radiology Radiation Oncology
Clinical Trials
- Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Start of enrollment: 2002 Feb 01
- Study of Tissue and Blood Samples From Patients With Low-Grade Glioma Start of enrollment: 1995 Dec 01
Publications & Presentations
PubMed
- 20 citationsDouble-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial o...Aarti K. Bhatia, Ju Whei Lee, Harlan A. Pinto, Charlotte Jacobs, Paul J. Limburg
Cancer. 2017-12-01 - 99 citationsValidation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51Thomas B. Daniels, Paul D. Brown, Sara J. Felten, Wenting Wu, Jan C. Buckner
International Journal of Radiation Oncology, Biology, Physics. 2011-09-01 - 5 citationsPhase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.Kurt A. Jaeckle, Karla V. Ballman, Caterina Giannini, Paula J. Schomberg, Matthew M. Ames
Journal of Neuro-Oncology. 2010-01-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: